Deep Convolutional Neural Support Vector Machines for the Classification of Basal Cell Carcinoma Hyperspectral Signatures.
Lloyd A CourtenayDiego Gonzalez-AguileraSusana LagüelaSusana Del PozoCamilo RuizInés Barbero-GarcíaConcepción Román-CurtoJavier CañuetoCarlos Santos-DuránMaría Esther Cardeñoso-ÁlvarezMónica Roncero-RiescoDavid Hernandez-LopezDiego Guerrero-SevillaPablo Rodríguez-GonzalvezPublished in: Journal of clinical medicine (2022)
Non-melanoma skin cancer, and basal cell carcinoma in particular, is one of the most common types of cancer. Although this type of malignancy has lower metastatic rates than other types of skin cancer, its locally destructive nature and the advantages of its timely treatment make early detection vital. The combination of multispectral imaging and artificial intelligence has arisen as a powerful tool for the detection and classification of skin cancer in a non-invasive manner. The present study uses hyperspectral images to discern between healthy and basal cell carcinoma hyperspectral signatures. Upon the combined use of convolutional neural networks, with a final support vector machine activation layer, the present study reaches up to 90% accuracy, with an area under the receiver operating characteristic curve being calculated at 0.9 as well. While the results are promising, future research should build upon a dataset with a larger number of patients.
Keyphrases
- skin cancer
- basal cell carcinoma
- deep learning
- artificial intelligence
- convolutional neural network
- machine learning
- end stage renal disease
- big data
- squamous cell carcinoma
- small cell lung cancer
- high resolution
- ejection fraction
- prognostic factors
- chronic kidney disease
- peritoneal dialysis
- genome wide
- young adults
- squamous cell